Literature DB >> 9333239

Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent.

M E Bruce1, R G Will, J W Ironside, I McConnell, D Drummond, A Suttie, L McCardle, A Chree, J Hope, C Birkett, S Cousens, H Fraser, C J Bostock.   

Abstract

There are many strains of the agents that cause transmissible spongiform encephalopathies (TSEs) or 'prion' diseases. These strains are distinguishable by their disease characteristics in experimentally infected animals, in particular the incubation periods and neuropathology they produce in panels of inbred mouse strains. We have shown that the strain of agent from cattle affected by bovine spongiform encephalopathy (BSE) produces a characteristic pattern of disease in mice that is retained after experimental passage through a variety of intermediate species. This BSE 'signature' has also been identified in transmissions to mice of TSEs of domestic cats and two exotic species of ruminant, providing the first direct evidence for the accidental spread of a TSE between species. Twenty cases of a clinically and pathologically atypical form of Creutzfeldt-Jakob disease (CJD), referred to as 'new variant' CJD (vCJD), have been recognized in unusually young people in the United Kingdom, and a further case has been reported in France. This has raised serious concerns that BSE may have spread to humans, putatively by dietary exposure. Here we report the interim results of transmissions of sporadic CJD and vCJD to mice. Our data provide strong evidence that the same agent strain is involved in both BSE and vCJD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333239     DOI: 10.1038/39057

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  448 in total

Review 1.  Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease.

Authors:  P Brown
Journal:  BMJ       Date:  2001-04-07

Review 2.  Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.

Authors:  H M Chapel
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 3.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

Review 4.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

5.  A policy analysis of major decisions relating to Creutzfeldt-Jakob disease and the blood supply.

Authors:  K Wilson; P C Hébert; A Laupacis; C Dornan; M Ricketts; N Ahmad; I Graham
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

6.  Genome-wide search for markers associated with bovine spongiform encephalopathy.

Authors:  Jules Hernández-Sánchez; Dave Waddington; Pamela Wiener; Chris S Haley; John L Williams
Journal:  Mamm Genome       Date:  2002-03       Impact factor: 2.957

Review 7.  New variant Creutzfeldt-Jakob disease: the epidemic that never was.

Authors:  G A Venters
Journal:  BMJ       Date:  2001-10-13

8.  Rapid prion neuroinvasion following tongue infection.

Authors:  Jason C Bartz; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 9.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

10.  Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.

Authors:  Sandra Müller; Roland Kehm; Michaela Handermann; Nurith J Jakob; Udo Bahr; Björn Schröder; Gholamreza Darai
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.